
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
VV116 as a potential treatment for COVID-19
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 675-678
Closed Access | Times Cited: 7
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 675-678
Closed Access | Times Cited: 7
Showing 7 citing articles:
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
Ellen Van Damme, Pravien Abeywickrema, Yanting Yin, et al.
Nature (2025)
Open Access | Times Cited: 1
Ellen Van Damme, Pravien Abeywickrema, Yanting Yin, et al.
Nature (2025)
Open Access | Times Cited: 1
Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis
Giacomo Berti, Daniele Mengato, Honoria Ocagli, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Giacomo Berti, Daniele Mengato, Honoria Ocagli, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase
Zherui Zhang, Hongqing Zhang, Yanan Zhang, et al.
Virologica Sinica (2023) Vol. 38, Iss. 3, pp. 470-479
Open Access | Times Cited: 10
Zherui Zhang, Hongqing Zhang, Yanan Zhang, et al.
Virologica Sinica (2023) Vol. 38, Iss. 3, pp. 470-479
Open Access | Times Cited: 10
Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)
Qiuyu Cao, Yi Ding, Yu Xu, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1068-1079
Closed Access | Times Cited: 7
Qiuyu Cao, Yi Ding, Yu Xu, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1068-1079
Closed Access | Times Cited: 7
Remdesivir Derivative VV116 Is a Potential Broad-Spectrum Inhibitor of Both Human and Animal Coronaviruses
Weiyong Liu, Min Zhang, Chieh-Ju Hu, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2295-2295
Open Access | Times Cited: 6
Weiyong Liu, Min Zhang, Chieh-Ju Hu, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2295-2295
Open Access | Times Cited: 6
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein
Marnix Van Loock, Ellen Van Damme, Pravien Abeywickrema, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Marnix Van Loock, Ellen Van Damme, Pravien Abeywickrema, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
How Much Potential Do Nucleoside Analogs Offer to Combat Human Corona Viruses?
Włodzimierz Buchowicz, Mariola Koszytkowska‐Stawińska
Organics (2024) Vol. 5, Iss. 2, pp. 71-110
Open Access
Włodzimierz Buchowicz, Mariola Koszytkowska‐Stawińska
Organics (2024) Vol. 5, Iss. 2, pp. 71-110
Open Access